Dr. Michael J. Goodheart, MD

Dr. Goodheart practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Goodheart's NPI, 1811985666, was assigned on October 6, 2005. Dr. Goodheart graduated from Brody School of Medicine at East Carolina University in 1995. Dr. Goodheart holds Iowa license 33538.

Dr. Goodheart's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Goodheart's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Goodheart is also affiliated with Monument Health Rapid City Hospital. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Goodheart to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodheart practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Goodheart's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Goodheart is licensed in Iowa.

CMS data shows 209 Medicare services from Dr. Goodheart across 7 procedure codes in 2024, for 112 Medicare patients. Medicare paid $25,968 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 112 Medicare patients who saw Dr. Goodheart in 2024. The largest group is 65 to 74, with 57 patients. 71% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goodheart's median patient age at 72, with 100% women.

In 2024, Dr. Goodheart wrote 35 Medicare Part D claims for 16 patients. 77% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $46,526 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Goodheart for performance year 2024, reported as part of a group. Dr. Goodheart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of removal of the uterus by Dr. Goodheart, more than 98% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 85 papers to Dr. Goodheart, published from 2007 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Cystadenocarcinoma, Serous. Dr. Goodheart has published most often in Gynecol Oncol. Dr. Goodheart's most frequent co-authors are David P. Bender, MD, Premal Harish Thaker, MD and Kimberly Kay Leslie, MD.

Dmand AI links Dr. Goodheart to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Peripheral Nervous System Diseases and Neuromuscular Diseases.

CMS Open Payments shows 4 general payments to Dr. Goodheart from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $129.

Dr. Goodheart graduated from Brody School of Medicine at East Carolina University in 1995.